These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4539512)

  • 21. CD5+B cells in rheumatoid arthritis and Sjögren's syndrome.
    Maini RN; Plater-Zyberk C; Brown CM; Aghamohammadi S; Brennan FM; Feldmann M
    Clin Exp Rheumatol; 1990; 8 Suppl 5():67-8. PubMed ID: 1700941
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease.
    Scherbaum WA; Youinou PY; Le Goff P; Bottazzo GF
    Clin Exp Immunol; 1984 Mar; 55(3):516-8. PubMed ID: 6608424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid factors: what do they tell us?
    Newkirk MM
    J Rheumatol; 2002 Oct; 29(10):2034-40. PubMed ID: 12375308
    [No Abstract]   [Full Text] [Related]  

  • 24. A syndrome of multiple immune autoreactivity. A breakdown in immune regulation.
    Diaz LA; Glamb RW; Silva J
    Arch Dermatol; 1980 Jan; 116(1):77-9. PubMed ID: 6986118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome.
    Anderson LG; Tarpley TM; Talal N; Cummings NA; Wolf RO; Schall GL
    Clin Exp Immunol; 1973 Mar; 13(3):335-42. PubMed ID: 4573763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immune mechanisms in rheumatoid arthritis and Sjögren's syndrome.
    Whaley K; Glen AC; Deodhar SD; Dick WC; Nuki G; Buchanan WW
    Ann Rheum Dis; 1971 May; 30(3):332-3. PubMed ID: 5090255
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D; Waterman SA; Gordon TP
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periodontal disease in rheumatoid arthritis and Sjogren's syndrome: a modifiable risk factor for atherosclerosis?
    Rachapalli S
    Rheumatol Int; 2009 Feb; 29(4):479. PubMed ID: 18802700
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
    Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-antibody and other antiglobulin specificities in nonrheumatoid and rheumatoid effusion fluids and matched sera.
    Seward CW; Parker LP; Osterland CK
    J Lab Clin Med; 1974 Jan; 83(1):104-11. PubMed ID: 4543438
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.
    Kurki P; Helve T; Virtanen I
    J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
    Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
    J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ribosomal protein L7 as an autoantigen in patients with systemic lupus erythematosus, mixed collagen disease and rheumatoid arthritis].
    von Mikecz A; Hemmerich P; Neu E; Peter HH; Krawinkel U
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):501-3. PubMed ID: 7856252
    [No Abstract]   [Full Text] [Related]  

  • 35. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sjögren's syndrome with anticentromere antibodies.
    Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
    Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of D-penicillamine on the latex fixation test, hemagglutination test and streptococci-L-agglutination in vitro].
    Keil E; Schütz M; Tanner E; Seidel K
    Z Gesamte Inn Med; 1971 Jan; 26(2):83-5. PubMed ID: 5314856
    [No Abstract]   [Full Text] [Related]  

  • 38. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis.
    Elkon KB; Gharavi AE; Patel BM; Hughes GR; Frankel A
    Clin Exp Immunol; 1983 Apr; 52(1):75-84. PubMed ID: 6861373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies and the autoimmune diseases.
    Josephson AS
    Bull N Y Acad Med; 1981 Sep; 57(7):631-7. PubMed ID: 6974027
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
    Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.